Fisker (FSR) to Enter India Market with Ocean and PEAR
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500, Dow set to open lower as Gulf tensions send oil to over six-week high
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- Trump says Canada's Bombardier must build jets in US or lose market access
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- European shares subdued as surging crude sharpens focus on ECB rate path
- S&P 500, Dow set to open lower as Gulf tensions send oil to over six-week high
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Fisker (FSR) Partners with Wallbox (WBX) for EV Charging
September 20, 2022 11:19 AM EDTSustainable Electric Vehicle manufacturer, Fisker Inc. (NYSE: FSR) announced a partnership with energy management company, Wallbox (NYSE: WBX) for home EV charging solutions.
The partnership will allow Fisker to offer its EV customers Wallbox home EV chargers for purchase through the Fisker website in the U.S., Canada, and European launch markets. The Pulsar Plus, Wallbox's best-selling... More
Pre-Open Movers: Adobe Sinks on Deal to Acquire Figma, STOR Surges on Takeover
September 15, 2022 9:17 AM EDTPre-Open Stock Movers:
Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) 48% LOWER; announced topline results from the Phase 2 clinical trial of ELX-02 in combination with ivacaftor in Class 1 cystic fibrosis (CF) patients with at least one nonsense mutation. The combination trial of ELX-02 with ivacaftor was well tolerated but did not achieve statistical significance for efficacy endpoints, including changes from baseline in sweat chloride concentration (SCC) and percent forced expiratory volume (FEV1).
Fisker (FSR) Climbs Following New Buy Rating
September 15, 2022 8:50 AM EDTFisker (NYSE: FSR) climbed prior to the bell Thursday following a new Buy rating from Needham. Shares were up about 5.5%.
After-Hours Movers: Danaher Jumps on Spinoff Plans, Arconic Sinks on Lower Outlook
September 14, 2022 5:58 PM EDTAfter-Hours Stock Movers:
Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) 48% LOWER; announced topline results from the Phase 2 clinical trial of ELX-02 in combination with ivacaftor in Class 1 cystic fibrosis (CF) patients with at least one nonsense mutation. The combination trial of ELX-02 with ivacaftor was well tolerated but did not achieve statistical significance for efficacy endpoints, including changes from baseline in sweat chloride concentration (SCC) and percent forced expiratory volume... More
Needham Upgrades Tesla to Hold, Launches Coverage on 3 Other EV Stocks
September 14, 2022 5:19 PM EDTNeedham & Company has a new EV analyst, Vikram Bagri, who took over coverage of Tesla (NASDAQ: TSLA) and upgraded the shares to Hold from Underperform and launched coverage on three other EV stocks Fisker (Buy), Rivian (Hold), and Lucid (Underperform).
Tesla (NASDAQ: TSLA) was upgraded to hold from underperform. The analysts mentioned the following potential catalysts that could drive the stock higher: (1) renewed federal tax credit eligibility under... More
UPDATE: Needham & Company Assumes Fisker (FSR) at Buy
September 14, 2022 4:10 PM EDT(Updated - September 14, 2022 4:11 PM EDT)
Needham & Company analyst Vikram Bagri assumes coverage on Fisker (NYSE: FSR) with a Buy rating, PT $12.
The analyst comments "We are initiating coverage on Fisker (FSR) with a Buy rating and $12 PT. FSR is entering... More
